White House Announces New Agreements with Pharmaceutical Manufacturers to Lower Drug Prices

President Donald J. Trump announced nine new agreements with pharmaceutical manufacturers to lower prescription drug prices for Americans, aligning prices with the lowest paid by other developed nations through "most-favored-nation" (MFN) pricing. These agreements bring the total number of manufacturers with MFN deals to 26, covering 89% of the branded drug market, and are expected to reduce prices on drugs for various costly and chronic diseases.